Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Rethinking the clinical research protocol: Lessons learned from the COVID-19 pandemic and recommendations for reducing noncompliance
0
Zitationen
6
Autoren
2024
Jahr
Abstract
These noncompliance events have implications for clinical trial methodology because nonadherence to trial design can lead to participant safety concerns and loss of trial data validity. Protocols should be written to better facilitate the capture of all safety and efficacy data. This recommendation should be considered when changes occur to the protocol environment that are outside of the study team's control.
Ähnliche Arbeiten
World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects
2003 · 10.819 Zit.
Estimating the mean and variance from the median, range, and the size of a sample
2005 · 8.928 Zit.
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 · 6.943 Zit.
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
2020 · 5.220 Zit.
The global landscape of AI ethics guidelines
2019 · 4.504 Zit.